Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03508934 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes
A NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 218
- Enrollment target
- 1
- Study location
NCT03508934: Active NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, sponsored by VA Office of Research and Development.
NCT03508934 is a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 218 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03508934, a NA study of Diabetes Mellitus, Type 2 and Hypoglycemia, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is disproportionally higher. It is estimated that 40-50% of hospitalized Veterans are diabetics. In this clinical trial the investigators describe the development of a novel system, the Glucose Telemetry System (GTS), with which glucose values can be wirelessly transmitted from the patient's bedside to a monitor device at the nursing station. The goal of this work is to develop a more effective glucose surveillance system at the general wards, which can decrease hypoglycemia in the hospital and improve clinical outcomes.
Primary Outcome
GTS and the application of the hypoglycemia prevention protocol will lead to a decrease in hypoglycemia in the hospital
Conditions Studied
Interventions
- DEVICE GTS (Continuous Glucose Monitoring)
- OTHER POC (Point of Care)
Study Locations (1)
Maryland
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT03508934 still lists
NCT03508934 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which GTS (Continuous Glucose Monitoring) is the first listed.
NCT03508934 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03508934 about?
NCT03508934 is a clinical study titled "Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes". More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is d...
What is the current status of trial NCT03508934?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 218 participants. The study started on 2018-07-01. Estimated completion is 2026-04-30.
What conditions does trial NCT03508934 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Hypoglycemia.
What interventions are being tested in trial NCT03508934?
The interventions under investigation include: GTS (Continuous Glucose Monitoring) (DEVICE), POC (Point of Care) (OTHER).
Who is sponsoring clinical trial NCT03508934?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03508934 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03508934's enrollment target sits among peer trials
218 145th of 348 higher than 203 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI